Introducing ifosfamide in innovative treatment modalities

Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings.

Immunotherapy·2020

Basket trials: From tumour gnostic to tumour agnostic drug development.

Cancer treatment reviews·2020

Biomimetic membranes designed from amphiphilic block copolymers.

Soft matter·2020

A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer.

Cancer chemotherapy and pharmacology·2019

Phase Ib trial combining capecitabine, erlotinib and bevacizumab in pancreatic adenocarcinoma - REBECA trial.

Investigational new drugs·2018

Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations.

Cancer discovery·2018

The value of target-site physiologically-based pharmacokinetics for high-affinity small molecules: a mechanistic foundation for precision dosing in oncology and hematology.

Cancer chemotherapy and pharmacology·2026

Pharmacologic de-escalation of dexamethasone during weekly paclitaxel: a randomized phase III trial evaluating safety, endocrine effects, and quality of life.

Cancer chemotherapy and pharmacology·2026

Design characteristics of mass balance studies conducted for protein kinase inhibitors.

Cancer chemotherapy and pharmacology·2026

Anti-PD-1 single-chain variable fragments in cancer immunotherapy: from molecular engineering to clinical translation.

Cancer chemotherapy and pharmacology·2026

Successful oral desensitization to temozolomide in a patient with immediate hypersensitivity reaction.

Cancer chemotherapy and pharmacology·2026

Pharmacokinetics of asciminib in a patient with chronic myeloid leukemia undergoing maintenance hemodialysis.

Cancer chemotherapy and pharmacology·2026

Development of a Novel, Eco-Friendly Mechanical Cell Lysis Process Using Hollow Fiber Filter for AAV Manufacturing.

Biotechnology and bioengineering·2026

Programmed repair of disease-causing UGA premature termination codons in mammalian brain.

Nucleic acids research·2026

Case Report: Novel homozygous pathogenic variant of the SPG20 gene causes the Troyer syndrome in China.

Frontiers in genetics·2026

Molecular profiling and functional analyses of umbilical cord mesenchymal stem cell-derived extracellular vesicles for dry eye diseases.

Extracellular vesicles and circulating nucleic acids·2026

Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives.

Frontiers in immunology·2026

Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis After Failure of Ustekinumab: A Multicenter Retrospective Study.

The Journal of clinical and aesthetic dermatology·2026

Related Experiment Videos

Introducing ifosfamide in innovative treatment modalities

Related Concept Videos

Pasotuxizumab, a BiTE<sup>®</sup> immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings.

Basket trials: From tumour gnostic to tumour agnostic drug development.

Biomimetic membranes designed from amphiphilic block copolymers.

A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer.

Phase Ib trial combining capecitabine, erlotinib and bevacizumab in pancreatic adenocarcinoma - REBECA trial.

Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with <i>FGFR3</i> Alterations.

The value of target-site physiologically-based pharmacokinetics for high-affinity small molecules: a mechanistic foundation for precision dosing in oncology and hematology.

Pharmacologic de-escalation of dexamethasone during weekly paclitaxel: a randomized phase III trial evaluating safety, endocrine effects, and quality of life.

Design characteristics of mass balance studies conducted for protein kinase inhibitors.

Anti-PD-1 single-chain variable fragments in cancer immunotherapy: from molecular engineering to clinical translation.

Successful oral desensitization to temozolomide in a patient with immediate hypersensitivity reaction.

Pharmacokinetics of asciminib in a patient with chronic myeloid leukemia undergoing maintenance hemodialysis.

Development of a Novel, Eco-Friendly Mechanical Cell Lysis Process Using Hollow Fiber Filter for AAV Manufacturing.

Programmed repair of disease-causing UGA premature termination codons in mammalian brain.

Case Report: Novel homozygous pathogenic variant of the <i>SPG20</i> gene causes the Troyer syndrome in China.

Molecular profiling and functional analyses of umbilical cord mesenchymal stem cell-derived extracellular vesicles for dry eye diseases.

Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives.

Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis After Failure of Ustekinumab: A Multicenter Retrospective Study.

Related Experiment Videos

Introducing ifosfamide in innovative treatment modalities

Related Concept Videos

Related Articles